Kevin Smith IPS

Kevin Smyth is a chartered biochemical engineer with over 30 years’ global experience in the design of biopharmaceutical manufacturing facilities. He has led multiple large molecule biologics, vaccines, and sterile fill-finish projects, from the development of project scope, front-end planning, feasibility studies to detailed design. Kevin has extensive biopharmaceutical process design experience, including facility scoping, layout development, regulatory compliance, high containment of toxins and potent biologics , technology evaluation, safety reviews (Hazops/FMEAs), PFD/P&ID design and equipment selection. Kevin is an active committee member of the PDA and ISPE Ireland Committees and has regularly chaired, presented at and organised technical seminars in Ireland/Europe for these organisations. Kevin possesses excellent technical knowledge and has a passion for innovation in design.